Order Article Reprints

Sprüssel A, Suzuki T, Miyata N, Astrahantseff K, Szymansky A, Toedling J, Thole-Kliesch TM, Ballagee A, Lodrini M, Künkele A, et al. Targeting KDM1A in Neuroblastoma with NCL-1 Induces a Less Aggressive Phenotype and Suppresses Angiogenesis. Journal of Clinical Medicine. 2024; 13(20):6081. https://doi.org/10.3390/jcm13206081

Sprüssel, Annika, Takayoshi Suzuki, Naoki Miyata, Kathy Astrahantseff, Annabell Szymansky, Joern Toedling, Theresa M. Thole-Kliesch, Annika Ballagee, Marco Lodrini, Annette Künkele, and et al. 2024. "Targeting KDM1A in Neuroblastoma with NCL-1 Induces a Less Aggressive Phenotype and Suppresses Angiogenesis" Journal of Clinical Medicine 13, no. 20: 6081. https://doi.org/10.3390/jcm13206081

Sprüssel, A., Suzuki, T., Miyata, N., Astrahantseff, K., Szymansky, A., Toedling, J., Thole-Kliesch, T. M., Ballagee, A., Lodrini, M., Künkele, A., Truss, M., Heukamp, L. C., Mathia, S., Hertwig, F., Rosenberger, C., Eggert, A., Deubzer, H. E., & Schulte, J. H. (2024). Targeting KDM1A in Neuroblastoma with NCL-1 Induces a Less Aggressive Phenotype and Suppresses Angiogenesis. Journal of Clinical Medicine, 13(20), 6081. https://doi.org/10.3390/jcm13206081